Selected publications

  • Hinke DM, Anderson AM, Katta K, Laursen MF, Tesfaye DY, Werninghaus IC, Angeletti D, Grødeland G, Bogen B* and Braathen R*. ”Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins”. Nat Commun. 2024 Feb 12;15(1):850. doi: 10.1038/s41467-024-44889-w. *Authors are senior co-authors. #
  • Westhrin M, Blazevski J, Textor, A, Abdollahi P, Gopalakrishnan RP, Ngo L, Hofgaard PO, Heinzelbecker J, Bobic S, Fossum E, Spång HCL, Braathen R* and Bogen B*. “Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM”. J Immunother Cancer. 2023. 11(8):e006944. doi: 10.1136/jitc-2023-006944. *Authors are senior co-authors.  #
  • Werninghaus IC, Hinke DM, Fossum E, Bogen B and Braathen R. “Neuraminidase delivered as an antigen presenting cell-targeted DNA vaccine induces protective antibodies against influenza”. Mol. Ther., 2023 16:S1525-0016(23)00133-8. doi: 10.1016/j.ymthe.2023.03.012. #
  • Hinke DM, Andersen TK, Gopalakrishnan RP, Skullerud LM, Werninghaus IC, Grødeland G, Fossum E, Braathen R* and Bogen B*. ”Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses”. Cell Rep., 2022.39;9:110901. *Authors are senior co-authors. #
  • Tesfaye DY, Bobic S. Lysen A. Huszthy PC, Gudjonsson A, Braathen R, Bogen B and Fossum E. “Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection”. Front. Immunol., 2022, 28;13:752714. doi: 10.3389/fimmu.2022.752714.
  • Bjerkan L, Visweswaran GRR, Gudjonsson A, Labbé GM, Quinkert D, Pattinson DJ, Spång HCL, Draper SJ*, Bogen B*, Braathen R*. “APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell Responses”. Front. Immunol., 2021, 18;12:720550. doi: 10.3389/fimmu.2021.720550 *Authors are senior co-authors. #
  • Fossum E, Tesfaye DY, Bobic S, Gudjonsson A, Braathen R, Lahoud MH, Caminschi I,  and Bogen B.” Targeting antigen to different receptors on conventional type 1 dentritic cells impact the immune response”. J. Immunol. 2020, 1;205:661-673
  • Braathen R,  Spång HCL, Hinke DM, Blazevski J, Bobic S, Fossum E, and Bogen B. “A DNA vaccine that encodes an antigen presenting cell-specific heterodimeric protein protects against cancer and influenza”. Mol Ther Methods Clin Dev. 2020, 25;17:378-392. #
  • Huszthy PC, Gopalakrishnan RP, Jacobsen JT, Haabeth OAW, Løset GÅ, Braathen R, Schenck K, Tveita AA, Munthe LA, and Bogen B. “B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells”. Proc Natl Acad Sci U S A. 2019, 17;116:25850-25859.
  • Mahalunkar SA, Yadav AS, Gorain M, Pawar V, Braathen R, Weiss S, Bogen B, Gosavi SW and Kundu GC. "Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer". Int. J. Nanomedicine. 2019, 15;14:8285-8302.
  • Lysen A, Braathen R, Gudjonnson A, Tesfaye DY, Bogen B, and Fossum E. “Dendritic cell targeted CCL3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site”. Scientific Reports. 2019, 12; 9:1820
  • Anderson AM, Baranowska-Hustad M, Braathen R, Grodeland G, and Bogen B. “Simultaneous targeting of multiple hemagglutinins to APCs for induction of broad immunity against influenza”. 2018. J.Immunol. 2018, ji1701088; DOI: https://doi.org/10.4049/jimmunol.1701088
  • Braathen R, Spång HCL, Lindeberg MM, Fossum E, Grødeland G, Fredriksen AB, and Bogen B. ”The magnitude and IgG subclass of antibodies elicited by targeted DNA vaccines are influenced by specificity for APC surface molecules”. ImmunoHorizons. 2018, 2:38-53. #
  • Spång HCL, Braathen R* and Bogen B*. Heterodimeric barnase-barstar vaccine molecules: Influence of one versus two targeting units specific for antigen presenting cells. PloS ONE. 2012, 7:e45393. *Authors are senior co-authors. #
Published July 31, 2012 3:14 PM - Last modified Oct. 16, 2025 4:10 PM
E-mail this page